ライフサイエンスコーパス: I

1 I argue that this distinction has been neglected by rese

2 I characterize the typical learning performance in terms

3 I have been researching coronaviruses for more than fort

4 I have had the privilege to work in institutions in four

5 'I have not found among my possessions anything which I h

6 I review theoretical understanding of this phenomenon (s

7 I summarize evidence for such 'catastrophe compassion',

8 I(2) was 98% at 1.5 T and 3.0 T.

9 ic complete response) rate was 53% and RCB-0/I was 63%.

10 ratio, 1.24; 95% CI, 1.10-1.39; p = 0.0004; I = 0%).

11 MD -0.31 [95% CI -0.45 to -0.16], P < 0.001, I = 44.3, N = 1398).

12 %; and Hedge g 1.396, 95% CI 0.781 to 2.011, I = 84.02%, respectively).

13 heterogeneity test Q=527.33; tau(2)=0.0384; I(2)=95.05%; p<0.0001), with a significant increase in r

14 ed (Hedge g -1.486, 95% CI -1.884 to -1.089, I = 91.95%), whereas GLP-1 and PYY increased post-proced

15 as 72%, 33%, and 38%, respectively, for (123)I-MIBG WBS versus 83%, 75% and 54%, respectively, for (1

16 otope combinations of (99m)Tc, (111)In, (123)I, (177)Lu, and (201)Tl were performed with the NanoSPEC

17 3 PET/CT scans after administration of (124)I-MIBG, we estimated the effective dose of (124)I-MIBG.

18 IBG, we estimated the effective dose of (124)I-MIBG.

19 The in vitro cytotoxicity of (125)I-KX1 was assessed in 19 neuroblastoma cell lines, follo

20 adsorption of (129)IO(3)(-) compared to (129)I(-) in all soils and the complete reduction of (129)IO(

21 complete reduction of (129)IO(3)(-) to (129)I(-) within 5 h of addition.

22 31)I is effective, especially when high (131)I activities are used.

23 wing sarcoma, respectively) received IP (131)I-omburtamab administered on an outpatient basis.

24 IP RIT (131)I-omburtamab was well tolerated with minimal toxicities.

25 Conclusion: Lobar ablation with (131)I is effective, especially when high (131)I activities a

26 ly developed 2D perovskite (HA)(2) (GA)Pb(2) I(7) (HA=n-hexylammonium, GA=guanidinium).

27 associations of 17 diaryliodonium salts Ar(2)I(+)X(-) with 11 different Lewis bases (halide ions, car

28 and ~0.20% for MAPbI(3) and (BA)(2)(MA)Pb(2)I(7), respectively.

29 than in the SC (RR = 3.14, 95% CI 1.58-6.24, I(2) = 0).

30 um lead iodide, MAPbI(3), to MAPb(0.5)Sn(0.5)I(3)).

31 edure (Hedge g 1.095, 95% CI 0.509 to 1.642, I = 84.38%; and Hedge g 1.396, 95% CI 0.781 to 2.011, I

32 e and tert-butyl iodide molecules (i-C(3)H(7)I and t-C(4)H(9)I) through a conical intersection betwee

33 iodide molecules (i-C(3)H(7)I and t-C(4)H(9)I) through a conical intersection between (3)Q(0)/(1)Q(1

34 eviation) values for apolipoproteins B and A-I were 1.03 (0.24) g/L and 1.54 (0.27) g/L, respectively

35 60; 95% CI: 0.40-0.89), and apolipoprotein A-I (OR(1SD), 0.59; 95% CI, 0.37-0.93) were particularly l

36 95% CI, 1.01-2.33) and low apolipoprotein A-I levels (OR(1SD), 0.52; 95% CI, 0.31-0.88) were associa

37 sphingosine-1-phosphate and apolipoprotein A-I were associated with increased odds of acute coronary

38 r drive the progression of aristolochic acid I-induced CKD.

39 , II, and III, respectively (P < 0.001); AEG I was significantly (P< 0.001) associated with lower c (

40 < 0.001), and 76, 51, and 34 months for AEG I, II, and III, respectively (P < 0.001); AEG I was sign

41 elength of 414.234 (Fe I) nm and 396.054 (Al I) nm, and the kurtosis of spectra at wavelength ranges

42 ntially interact with the charged ends of an I-BAR domain, we find clustering of phosphatidylinositol

43 t fibres from frog skeletal muscle reveal an I-band spring with an undamped stiffness 100 times large

44 -term (Fe = 0.997, Cu = 0.506, Zn = 4.15 and I = 0.458 mg L(-1)) and mothers of full-term (Fe = 0.733

45 -term (Fe = 0.733, Cu = 0.234, Zn = 2.91 and I = 0.255 mg L(-1)) infants.

46 g by-products (bran, middlings, aleurone and I, II and III steps of debranning) and flour/semolina, u

47 k" Pettigrew, and outlines how Pettigrew and I conceived, proposed, tested, and developed two new sci

48 Cochran test and I(2) index were used to assess the heterogeneity of the

49 Colonization factor antigen I (CFA/I) fimbriae from Escherichia coli can inhibit aut

50 ls that recognize a major transplant antigen I-Ealpha from Balb/c mice.

51 airs the cholesterol efflux mediated by apoA-I or HDL3 in vitro and in vivo Using LC-MS/MS analysis,

52 In this article, I provide a full, exact, and universal mathematical desc

53 s a distinct creative effort of its authors, I would like to draw your attention to a number of theme

54 stinct CRISPR-Cas interference systems (I-B, I-A and III-B), only the I-B system and Cas3 were necess

55 r the treatment of schizophrenia and bipolar I disorder.

56 -mediated interaction between membrane-bound I-BAR domains.

57 r, patients with earlier Braak stages (Braak I-IV) did not show elevated tracer uptake in these regio

58 C-B or C-I suppressed colonosphere formation and inhibited expres

59 ine-dependent K(+) current (I(KACh)), called I(KH); this is an important mechanism underlying not onl

60 Colonization factor antigen I (CFA/I) fimbriae from Escherichia coli can inhibit autoimmune

61 Class I adenylate-forming enzymes share a conserved structural

62 a-2-microglobulin (beta2M) and affects class I Ag presentation through sequestration of beta2M inside

63 rapy, which significantly reduced both class I and II HLA antibodies and increased the likelihood of

64 ds on major histocompatibility complex class I (MHC I) molecules loaded with peptides.

65 oaded major histocompatibility complex class I (pMHCI) tetramer technology.

66 culated panel reactive antibody [cPRA] class I and/or II >99%, complement-dependent cytotoxicity pane

67 observed that individuals carrying HLA class I genotypes characterized by greater tapasin independenc

68 These models predicted endogenous HLA class I-associated ligands with 1.5-fold improvement in positi

69 (DCs), as well as up-regulation of MHC class I and down-regulation of checkpoint regulator PD-L1 on t

70 tion increased expression of CD54, MHC Class I and II molecules in endothelial but not epithelial cel

71 n silico analysis of viral peptide-MHC class I binding affinity across 145 HLA-A, -B, and -C genotype

72 ward comprehensive modeling of the MHC class I pathway.

73 tation on the cell surface through MHC class I.

74 h contributes toward inhibition of MHC class I:beta2M:peptide complex formation.

75 rough interaction with the proteins of class I and class II major histocompatibility complex (MHC) pa

76 des predicted to bind a broad range of class I and II HLA molecules were selected for in vitro screen

77 Here, we report that inhibition of class I PI3K or PDPK1 activates CMA.

78 the regulated transporter activity of class I proteins is becoming better understood, class III prot

79 A phylogenetic analysis of class I RNRs suggests that activity regulation is not ancestra

80 an important first step in repurposing class I PI3K inhibitors to modulate CMA in vivo.

81 The class I pathway requires MSH4 and MSH5 (MutSgamma) to maintain

82 us-7 (HHV-7) U21 glycoprotein binds to class I major histocompatibility complex (MHC) molecules in th

83 The resulting single-component Co(-I) complex is proposed as the direct pre-catalyst.

84 more active than traditional neutral cobalt(I) catalysts and approach rhodium catalysts in activity

85 In parallel, collagen I and III showed a selective and progressive increase ov

86 2 (Nrf2) enables idebenone to bypass Complex I in cells with poor NQO1 expression.

87 TNFR1-containing signaling complex (complex I), RIPK1 ubiquitination, and NF-kappaB activation.

88 on treatment promoted NQO1-dependent Complex I bypass activity in these cells.

89 nt is the alleged destabilization of complex I in the absence of complex III.

90 units in oxidative phosphorylation complexes I and V increased in CLPP2 knockouts, without accumulati

91 imaging, we demonstrate that both condensin I and II exhibit ATP-dependent motor activity and promot

92 In mixtures of condensins I and II, coupling two-sided extrusion and stable chroma

93 After induction of a specific context, I measured peri-saccadic suppression.

94 d crossing pattern formed only with a copper(I)-coordinated crossing of particular handedness.

95 glycerol in females only in cerebellar Crus I; and (3) increased dorsal hippocampus prostaglandins i

96 Glaser coupling product ArC=C-C=CAr and [Cu(I)](solvent).

97 e thiol-rich reducing molecules with high Cu(I) affinity, they are potential competitors for a copper

98 on with reduced Hypocrea jecorina LPMO9A (Cu(I)-HjLPMO9A) is demonstrated to be 1,000-fold faster tha

99 esults in an almost complete reduction to Cu(I), under the formation of N(2).

100 sium channel expression (Kv1.5) and current (I(Kur)) and F(2)-isoprostanes, NOX2, and PKC-alpha/delta

101 orm of acetylcholine-dependent K(+) current (I(KACh)), called I(KH); this is an important mechanism u

102 Na(+)-K(+) pump current, I(p), was measured in voltage-clamped myocytes from noni

103 ation of recombinant human deoxyribonuclease I (rhDNase) to polyethylene glycol (PEG) of 20 to 40 kDa

104 rimental techniques we have at our disposal, I propose a broad classification of techniques into six

105 mes the physiological concentration of DNase I.

106 Dy-I-PhiAB6TSP also cross-reacted with other pathogenic bac

107 Balance between excitation and inhibition (E-I balance) in neural circuits is believed to be tightly

108 rotransmission, and excitation-inhibition (E-I) balance.

109 of postsynaptic excitation to inhibition (E/I ratio) imbalances in human brain diseases, is a highly

110 rated alteration of excitation/inhibition (E/I) balance and aberrant synaptic plasticity at the corti

111 ions on the function and regulation of the E/I balance.

112 uman brains as well as the transcriptional E/I (tE/I) ratio.

113 of the C-terminal domain of bacterial Enzyme I (EIC).

114 Cardiac sodium channel expression, I(Na) and atrial action potential duration were reduced

115 of spectra at the wavelength of 414.234 (Fe I) nm and 396.054 (Al I) nm, and the kurtosis of spectra

116 .0-2.9)/100 person-years after ART in Fiebig I to 15.9 (7.6-29.2) in Fiebig V.

117 Finally, I provide some suggestions for future research within th

118 mice develop adverse LV remodeling following I/R injury secondary to the collateral damage from susta

119 gBT-I.1-vaccinated mice did not generate a robust neutraliza

120 ion can trigger retinoic acid-inducible gene I (RIG-I)/mitochondrial antiviral signaling (MAVS)-depen

121 first crystal structure of mammalian ER Glu I will constitute the basis for the development of poten

122 one-pot, multistep process entailing a gold(I)-catalyzed propargyl Claisen rearrangement/Nazarov cyc

123 terize the biological activity of these gold(I) complexes, we used a series of time-kill studies, cyt

124 ound in 23 (11%) patients, dysfunction grade I in 107 (51%), grade II in 31 (14.8%), and grade III in

125 and 0% for World Health Organization grades I, II, and III, respectively.

126 In group I, CFT, IRT, ORT, foveal SCP-VD, and foveal DCP-VD were

127 ) due to recurrent non-resolving VH in group I. late recurrent VH occurred in two eyes (11.8%) in gro

128 cal lesion with periodontal bone loss; Group I (intermediate) in which the border of the furcal lesio

129 n of mGluR1 and mGluR5, members of the group I mGluR family.

130 Prototheca zopfii GT-II (but not GT-I) invaded bovine and murine mammary epithelial cells (M

131 was encountered for off-targets, such as hCA I and II.

132 Here I consider that obligation may also develop "from the ou

133 Here, I describe recent progress in understanding the evolutio

134 Here, I discuss the similarities and differences between MIS-C

135 Here, I provide my perspective on four key areas that need fur

136 Here, I review the state of this new wave of research.

137 Here, I study the variation of species presence and abundance

138 Here, I use an advanced energy balance model to show that such

139 ta-analysis revealed moderate heterogeneity (I(2) = 62%).

140 We find that the photochemistry of Hg(I) and Hg(II) leads to insufficient Hg oxidation globall

141 oss-recognized variant epitopes encoding HLA-I-associated adaptations, further supporting our conclus

142 sses of kinase inhibitors including types I, I(1)/(2), and II as well as allosteric inhibitors.

143 antagonistic caspase that downregulates IFN-I production.

144 Type I IFN (IFN-I) is thought to be rapidly internalized and degraded fo

145 lls (pDCs) produce abundant type I IFNs (IFN-I) in response to viral nucleic acids.

146 bstantially attenuated in the context of IFN-I pretreatment, whereas SARS-CoV is not.

147 viruses have evolved countermeasures to IFN-I restriction, and genetic loss of viral IFN-I antagonis

148 are largely dormant functionally, due to IFN-I-induced negative regulators.

149 f3ip3 have increased RNA virus-triggered IFN-I production and reduced susceptibility to virus.

150 I restriction, and genetic loss of viral IFN-I antagonists leads to virus attenuation.

151 nuates disease only in mice treated with IFN-I.

152 enhanced autophagy (increased LC3 and LC3-II/I ratio, and decreased p62/Sqstm1).

153 Imidazoline I(2) receptors (I(2)-IR), widely distributed in the CNS

154 lycocalyx is now considered a cornerstone in I/R-related endothelial dysfunction, which further impai

155 the mechanical stretch-mediated increase in I(Kv1.5) Our results further showed that the extracellul

156 ological techniques, we found an increase in I(Na,late) from -0.34 to -0.59 A F(-1) and a decrease in

157 ic disproportionation equilibrium between In(I), In metal, and In(III) opens up additional flexibilit

158 We found that increasing I above 1 m and adding diacids with oxygen-to-carbon mol

159 The low osmolarity-induced I(Kv1.5) increase also required an intact intracellular

160 to preserve the configurational information, I, and large-scale fluctuations, Q, of the microscopic m

161 key role in the PPP5C-FKBP51 axis to inhibit I(SOC) and protect the endothelial barrier against calci

162 are the major excitatory (E) and inhibitory (I) neurotransmitters in the brain, respectively.

163 tyrosine kinase that constitutively inhibits I(Kv1.5) Disrupting the Src-binding motif of Kv1.5 throu

164 Adenosine (A) to inosine (I) RNA editing contributes to transcript diversity and m

165 ion by volume (pptv) total inorganic iodine (I(y)) is injected to the stratosphere.

166 r borrowing hydrogen conditions, NHC-iridium(I) catalyzed the direct or one-pot sequential synthesis

167 reduced AF burden, restored I(Na), I(Ca,L), I(Kur), action potential duration, and reversed atrial f

168 Although LeuRS-I was not essential, its expression clearly supported op

169 clinical utility must be derived from level I evidence studies.

170 No level I evidence was available, and the existing level II and

171 (RPF), fat mass, and insulin sensitivity (M/I).

172 ern of chromosome segregation during meiosis I.

173 plex multivalent configurations at metaphase I, and in turn alter allelic segregation ratios through

174 ajor histocompatibility complex class I (MHC I) molecules loaded with peptides.

175 Here we show that, in PDAC, MHC-I molecules are selectively targeted for lysosomal degra

176 synergistic manner to facilitate both the Mn-I exchange and the C-C bond-forming steps.

177 Cr, Mn, Fe, Co, Cu, Zn, Se, Br, Rb, Sr, Mo, I, Cs, and Ba) in 10 muL of serum and 12 elements (Mg, S

178 s with the formula (A')(2) (A)(n) (-1) Pb(n) I(3) (n) (+1) have remarkable stability and promising ef

179 UW-3/Cx), D (UCI-96/Cx), E (IOL-43), or F (N.I.1).

180 The tris- and tetra-adducts of M(3)N@I(h)-C(80) metallofullerenes were synthesized and charac

181 The Na(+)/I(-) symporter (NIS), the plasma membrane protein that a

182 tioxidant reduced AF burden, restored I(Na), I(Ca,L), I(Kur), action potential duration, and reversed

183 ans from a structural point of view, and new I(2)-IR ligands are urgently required for improving thei

184 act alcove in forming and stabilizing the Ni(I)-CO intermediate in the Wood-Ljungdahl pathway of anae

185 e from the Fe(+III)/O(-II) to the Fe(+II)/O(-I) valence state.

186 e of activation and slow the deactivation of I(Ks).

187 Transduction of I/LnJ BMDMs with C57BL/6J CD300LF made the cells permiss

188 nine cardiomyocytes; however, its effects on I(to) in other species yet to be determined.

189 In chronological order, I have a B.A. in Scandinavian languages and literature f

190 ctive than TIV in preventing all-cause and P&I hospitalization from NHs during an A/H3N2 predominant

191 rmer and an "O" state in which d(z)(2) Ni(p)(I) (g( ) > g(||) ~ 2) surprisingly lacks CO.

192 o urea was achieved via unprecedented Ph(3)P-I(2) mediated ring-opening of 1,3-dihydro-1H-benzimidazo

193 The absence of PAP I led to improved aminoacylation of 5'-immature tRNAs.

194 on with a second transcription factor, PfAP2-I.

195 Moreover, data from a phase I study led to the FDA granting breakthrough therapy des

196 2017, with the following study design: phase I, 2-minute resting state at baseline (room air); phase

197 nome information along with an ensemble pMHC-I coding strategy, and developed a group feature selecti

198 Under identical conditions, purified Pol I and Pol III, but not Pol II, could transcribe nucleoso

199 Compound NS5806 has been shown to potentate I(to) in canine cardiomyocytes; however, its effects on

200 Imidazoline I(2) receptors (I(2)-IR), widely distributed in the CNS and altered in p

201 ith historical controls treated with regimen I.

202 r trigger a version of ischemia/reperfusion (I/R) pathobiology that is singular in its origin, cyclic

203 rial antioxidant reduced AF burden, restored I(Na), I(Ca,L), I(Kur), action potential duration, and r

204 plain the means by which s(2)C(32) restricts I(34) wobbling.

205 In this review, I discuss newly discovered neuronal circuits in primates

206 In this review, I will highlight new evidence indicating that neonatal T

207 ctic heteropolymer, rhamnogalacturonan I (RG-I).

208 le catalysis by stabilizing the reactive Rh(-I) species, which is responsible for cleaving the Ar-F b

209 the pectic heteropolymer, rhamnogalacturonan I (RG-I).

210 RIG-I, MDA5, and LGP2 comprise the RIG-I-like receptors (RLR

211 RIG-I-like receptors (RLR) are cytosolic RNA sensors that si

212 ions of DNA NANPs significantly enhances RIG-I mediated production of both proinflammatory cytokines

213 trigger retinoic acid-inducible gene I (RIG-I)/mitochondrial antiviral signaling (MAVS)-dependent re

214 RIG-I, MDA5, and LGP2 comprise the RIG-I-like receptors (RLRs).

215 ts with MAVS in microsomes, blocking the RIG-I/MAVS interaction.

216 ptor for the installation of a modified ring I.

217 in analogues, we describe a cleavage of ring I from paromomycin that proceeds in the presence of azid

218 tear volume was determined using Schirmer's I test (Basic Schirmer's test; BST), both preoperatively

219 an inheritance of the X-chromosome-shredding I-PpoI nuclease by coupling this to a CRISPR-based gene

220 le oxidants, such as benzoquinone and silver(I) salts.

221 tion with the isotype-specific inhibitor SK1-I in WT cells induced accumulation of cholesterol and re

222 CI, 1.6%-7.8%; 4 studies including 254 SOTR; I(2) = 17.6%).

223 The mRNA expression levels of ST6GAL-I and SOX9 in human gastric epithelial cells correlated

224 creased epithelial cell expression of ST6Gal-I is associated with premalignant progression.

225 These findings implicate up-regulated ST6Gal-I expression in blocking homeostatic epithelial cell apo

226 of DDX21 protein were found in 28% of stage I, 21% of stage II, 30% of stage III, and 32% of stage I

227 ified into 4 categories and nine strategies: I) Evaluate the progress of the procedure: inspection (1

228 nt improvements in 40-m sprint time in study I (compared to LR) and in star drill time in study II (n

229 ts, two of which were found to contain Sudan I and IV residues.

230 ibility study to identify and quantify Sudan I dye in ketchup samples using colour histograms (obtain

231 rfaces: (i) beta-interface, mapped to Switch I and effector-binding regions, (ii) alpha-interface at

232 ee distinct CRISPR-Cas interference systems (I-B, I-A and III-B), only the I-B system and Cas3 were n

233 rains as well as the transcriptional E/I (tE/I) ratio.

234 o neuropeptide release, we hypothesized that I(h) would be important for LNvs communication.

235 In this article, we investigated the I(2)-promoted cyclic dialkyl ether formation from 6-memb

236 rence systems (I-B, I-A and III-B), only the I-B system and Cas3 were necessary for priming.

237 We show, for the first time, that only the I-PI transition engages a brainstem-wide network, and th

238 Third, I describe the next generation of work on gene x environ

239 rticipants were recruited and randomized to (I) IDA alone, (II) IDA combined with AZI, (III) AZI alon

240 , can be repurposed to bind and isolate A-to-I edited transcripts from cellular RNA.

241 ma membrane protein that actively transports I(-) (stoichiometry 2Na(+):1I(-)) in thyroid physiology

242 of serum biomarkers (e.g., cardiac troponin I) afforded up to 130-fold enhancement of near-infrared

243 f transitioning from a conventional troponin I assay to a high-sensitivity assay with sex-specific th

244 amounts of myocardial injury (e.g., troponin I >0.03 to 0.09 ng/ml; n = 455; 16.6%) were significantl

245 0.001) while greater amounts (e.g., troponin I >0.09 ng/dl; n = 530; 19.4%) were significantly associ

246 Type I IFN (IFN-I) is thought to be rapidly internalized and

247 Type I IFN signaling caused tight junction dysregulation in I

248 Type I IFN-mediated JAK-STAT signaling is severely impaired,

249 Type I restriction-modification (R-M) systems consist of a DN

250 atory role by identifying interleukin 1 type I receptor kinase-1 (IRAK-1) as a Nck1-selective binding

251 on the alternative splicing of exon 1, type I splice variants (MOCS1A) either localize to the mitoch

252 Additionally, BMPR1, a type I BMP receptor normally required for BMP-mediated patter

253 With an 80% statistical power and a type I error probability of 0.1, 48 patients were to be accru

254 accinia virus, and Zika virus through a type I interferon (IFN)-independent mechanism.

255 rrelating with mitochondrial abundance, type I IFN signaling and effector immunity.

256 dendritic cells (pDCs) produce abundant type I IFNs (IFN-I) in response to viral nucleic acids.

257 relevant to the human disease, such as type I and II interferon signaling, cell-cell adhesion, leuko

258 bits the expression of genes induced by type I interferons.

259 membrane via a variant of the classical type I secretion system.

260 rboxyl-terminal telopeptide of collagen type I by 4% (95% CI: 1% to 8%; p = 0.02) compared with valsa

261 nonexpressing mice, but enrichment for type I interferon response gene changes was specifically obse

262 e potentials; the potassium efflux from type I hair cells results from the interdependent gating of t

263 ng viral HA-induced degradation of host type I IFN receptor.

264 However, type I collagen, RUNX2, type X collagen (CoL10A1), Osterix, a

265 ibuted PLIN2 to lipid droplet stores in type I fibres.

266 rtoires were associated with interferon type I and III responses, early CD4(+) and CD8(+) T cell acti

267 e new method is more powerful with less Type I error than the other two methods.

268 tive capacity (p = 0.0005) and are more type I interferon-resistant (p = 0.007) than those transmitte

269 tors had to be more than 6311 to obtain type I LacNAc tetrasaccharides in 72-86% yields, with minimal

270 is response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines

271 persists in vitro and has properties of Type I and Type II priming.

272 ibition of IFN-beta, a key component of type I IFN mechanisms to address its role in TBI pathophysiol

273 Interestingly, induction of type I IFNs after A. fumigatus challenge was only partially d

274 ent cells secreted increased amounts of type I interferon (IFN), which could be limited by CGAS or ST

275 phenotype accompanying inborn errors of type I interferon immunity.

276 toid DCs (pDCs), the major producers of type I interferon, are principally recognized as key mediator

277 une response and a modulatory impact on type I allergy is discussed.

278 ndoles on goblet cells do not depend on type I IFN or on IL-22 signaling, pathways responsible for pr

279 through adulthood, and requires ongoing type I IFN signaling to maintain it.

280 The poliovirus type I IRES is able to recruit ribosomal machinery only in th

281 e TLR7-mediated disease, which requires type I interferon (IFN) receptor signaling, TLR9-driven fatal

282 he relationship between hypoxia and the type I IFN pathway, which comprises the sensing of double-str

283 rogenous activation of six genes in the type I IFN pathway.

284 anoids have increased expression of the type I IFN receptor relative to neonate IECs, and the respons

285 rather than uniquely to antagonize the type I interferon response.

286 ument protein binds to a protein in the type I interferon signaling pathway Tyk2 and inhibits the exp

287 n in human and mouse cell lines through type I and type III IFNs.

288 of IFN-stimulated genes in response to type I IFN and leads to 1) promotion of cell-to-cell spread b

289 s, and the response of IEC organoids to type I IFN is strikingly increased in magnitude and scope rel

290 supports a developmental model in which Type-I and Type-II hair cells develop in parallel rather than

291 ortality were: P: age, gender and ACLF type; I: drug, infection, surgery, and variceal bleeding; R: s

292 classes of kinase inhibitors including types I, I(1)/(2), and II as well as allosteric inhibitors.

293 , while transformation from UBA III into UBA I still occurred in the presence of UBA III seeds.

294 Addition of UBA I seed crystals modified this pathway such that only UBA

295 als modified this pathway such that only UBA I was observed throughout, while transformation from UBA

296 e, based on a comparison of the two set-ups, I argue that these differences are unable to explain the

297 DC before (18)F-FDG PET/CT, Mayo staging was I/II in 8, III in 3, and IV in 10.

298 ot found among my possessions anything which I hold more dear than, or value so much as, my knowledge

299 etry 1Na(+):1ClO(4)(-)), which competes with I(-) for transport.

300 ng reaction of >P(O)H reagents with PhX (X = I and Br) in the presence of NiCl(2)/Zn as the precursor